EGFR-Mutated NSCLC: Clinical Practice Assessment and Gap Analysis

被引：0
|
作者：
Herrmann, Tara [1 ]
Hamarstrom, Elaine [2 ]
Ramalingam, Suresh [3 ]
机构：
[1] Medscape Educ, Ft Sam Houston, TX USA
[2] Medscape Educ, New York, NY USA
[3] Emory Univ, Winship Canc Inst, Med Oncol, Atlanta, GA 30322 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
EGFR; T790M; Education; molecular testing;
D O I：
10.1016/j.jtho.2016.11.1716
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.02b-049
引用
收藏
页码：S1218 / S1219
页数：2
相关论文
共 50 条
  • [31] Efficacy and safety of osimertinib in treating EGFR-mutated advanced NSCLC: A meta-analysis
    Yi, Lilan
    Fan, Junsheng
    Qian, Ruolan
    Luo, Peng
    Zhang, Jian
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (01) : 284 - 294
  • [32] A retrospective analysis of locally advanced EGFR-mutated NSCLC patients with durvalumab after chemoradiotherapy
    Uchida, Yoshiyasu
    Ninomiya, Takashi
    Harada, Daijiro
    Kozuki, Toshiyuki
    ANNALS OF ONCOLOGY, 2022, 33 : S488 - S488
  • [33] Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC
    Masahiro Tsuboi
    Roy S. Herbst
    Thomas John
    Terufumi Kato
    Margarita Majem
    Christian Grohé
    Jie Wang
    Jonathan W. Goldman
    Shun Lu
    Filippo de Marinis
    Frances A. Shepherd
    Ki Hyeong Lee
    Nhieu Thi Le
    Arunee Dechaphunkul
    Dariusz Kowalski
    Laura Bonanno
    Manuel Dómine
    Lynne Poole
    Ana Bolanos
    Yuri Rukazenkov
    Yi-Long Wu
    Targeted Oncology, 2024, 19 : 131 - 134
  • [34] Simulation in the Management of EGFR-Mutated Advanced NSCLC: Seeing Beyond Age
    Carey, Christine
    Herrmann, Tara
    Warters, Martin
    Blevins, Douglas
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (11) : S270 - S270
  • [35] Ablative Radiotherapy as a Strategy to Overcome TKI Resistance in EGFR-Mutated NSCLC
    Novak, Jennifer
    Salgia, Ravi
    West, Howard
    Villalona-Calero, Miguel A.
    Sampath, Sagus
    Williams, Terence
    Villaflor, Victoria
    Massarelli, Erminia
    Pathak, Ranjan
    Koczywas, Marianna
    Chau, Brittney
    Amini, Arya
    CANCERS, 2022, 14 (16)
  • [36] Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC
    Cho, Byoung C.
    Lu, Shun
    Felip, Enriqueta
    Spira, Alexander I.
    Girard, Nicolas
    Lee, Jong-Seok
    Lee, Se-Hoon
    Ostapenko, Yurii
    Danchaivijitr, Pongwut
    Liu, Baogang
    Alip, Adlinda
    Korbenfeld, Ernesto
    Mourao Dias, Josiane
    Besse, Benjamin
    Lee, Ki-Hyeong
    Xiong, Hailin
    How, Soon-Hin
    Cheng, Ying
    Chang, Gee-Chen
    Yoshioka, Hiroshige
    Yang, James C. -H.
    Thomas, Michael
    Nguyen, Danny
    Ou, Sai-Hong I.
    Mukhedkar, Sanjay
    Prabhash, Kumar
    D'Arcangelo, Manolo
    Alatorre-Alexander, Jorge
    Vazquez Limon, Juan C.
    Alves, Sara
    Stroyakovskiy, Daniil
    Peregudova, Marina
    Sendur, Mehmet A. N.
    Yazici, Ozan
    Califano, Raffaele
    Gutierrez Calderon, Vanesa
    de Marinis, Filippo
    Passaro, Antonio
    Kim, Sang-We
    Gadgeel, Shirish M.
    Xie, John
    Sun, Tao
    Martinez, Melissa
    Ennis, Mariah
    Fennema, Elizabeth
    Daksh, Mahesh
    Millington, Dawn
    Leconte, Isabelle
    Iwasawa, Ryota
    Lorenzini, Patricia
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (16): : 1486 - 1498
  • [37] Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy
    Aredo, Jacqueline V.
    Mambetsariev, Isa
    Hellyer, Jessica A.
    Amini, Arya
    Neal, Joel W.
    Padda, Sukhmani K.
    McCoach, Caroline E.
    Riess, Jonathan W.
    Cabebe, Elwyn C.
    Naidoo, Jarushka
    Abuali, Tariq
    Salgia, Ravi
    Loo Jr, Billy W.
    Diehn, Maximilian
    Han, Summer S.
    Wakelee, Heather A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (06) : 1030 - 1041
  • [38] Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC
    Tsuboi, Masahiro
    Herbst, Roy S.
    John, Thomas
    Kato, Terufumi
    Majem, Margarita
    Grohe, Christian
    Wang, Jie
    Goldman, Jonathan W.
    Lu, Shun
    de Marinis, Filippo
    Shepherd, Frances A.
    Lee, Ki Hyeong
    Le, Nhieu Thi
    Dechaphunkul, Arunee
    Kowalski, Dariusz
    Bonanno, Laura
    Domine, Manuel
    Poole, Lynne
    Bolanos, Ana
    Rukazenkov, Yuri
    Wu, Yi-Long
    TARGETED ONCOLOGY, 2024, 19 (02) : 131 - 134
  • [39] Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC
    Rosenfeld, Roberto
    NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (06): : 619 - 620
  • [40] Predictors of Health Utility Scores (HUS) in Advanced EGFR-Mutated NSCLC
    Jiang, S.
    Hurry, M.
    Hueniken, K.
    Brown, M. C.
    Liang, M.
    Patel, D.
    Labbe, C.
    Eng, L.
    Naik, H.
    Bradbury, P.
    Leighl, N.
    Shepherd, F.
    Xu, W.
    Liu, G.
    Walton, R.
    O'Kane, G.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S420 - S421
12345